References
Isaacson JE, Choe DJ, Doherty MJ (2014) Creatine phosphokinase elevation exacerbated by levetiracetam therapy. Epilepsy Behav Case Rep 2:189–191
Carnovale C, Gentili M, Antoniazzi S, Clementi E, Radice S (2017) Levetiracetam-induced rhabdomyolysis: analysis of reports from the Food and Drug Administration’s Adverse Event Reporting System database. Muscle Nerve 56(6):E176–E178
Kubota K, Yamamoto T, Kawamoto M, Kawamoto N, Fukao T (2017) Levetiracetam-induced rhabdomyolysis: a case report and literature review. Neurol Asia 22(3):275–278
Di Lorenzo R, Li Y (2017) Rhabdomyolysis associated with levetiracetam administration. Muscle Nerve 56(1):E1–E2
Shahbaz N, Younus SM, Khan SA, Ain Q, Khan MA, Memon MH (2017) Levetiracetam induced increase in creatine phosphokinase levels. J Coll Physicians Surg Pak 27(3):S63–S64
Zutt R, van der Kooi AJ, Linthorst GE, Wanders RJ, de Visser M (2014) Rhabdomyolysis: review of the literature. Neuromuscul Disord 24(8):651–659
Acknowledgements
The authors thank Mrs. Barbara Wade for her linguistic advice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Rota, E., Arena, L., Celli, L. et al. Levetiracetam-induced rhabdomyolysis: the first Italian case. Neurol Sci 39, 1629–1630 (2018). https://doi.org/10.1007/s10072-018-3421-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3421-3